DNMT3B can affect the formation of CHD through two different mechanisms: direct influence on the folate/methionine pathway by the modulation of cellular SAM levels, and globally through the methylation of the fetal genome which influences the expression of numerous genes. This evidence concerns the gene DNMT3B and coronary artery disorder.